Challenges in Managing Oral Manifestations of Anticonvulsant-Induced Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome
DOI:
https://doi.org/10.30659/odj.12.3.332-345Keywords:
DRESS Syndrome, oral manifestation, phenytoin, lamotrigine, temporal lobe epilepsy, affective bipolarAbstract
Background : Antiepileptic drugs were common causative agents for DRESS syndrome, which was a severe, idiosyncratic drug hypersensitivity reaction characterized by a prolonged latency period, fever, rash, and marked eosinophilia. The oral manifestations present a diagnostic challenge due its similarity to other hypersensitivity reactions as well as its comprehensive management. Objective: This case report aims to describe the challenges in comprehensive management of DRESS syndrome severe oral manifestations, highlighting the challenges from diagnosis to management for patient with complex comorbidities. Case: A 19-year-old female inpatient was referred to Oral Medicine division, Dental and Oro-maxillofacial unit of Universitas Indonesia Hospital (RSUI) for severe oral sores after treated with phenytoin and lamotrigine for her temporal lobe epilepsy and bipolar affective disorder. Patient shows general weakness and clinical examination revealed multiple intra oral erosions, lips erosions with exfoliation and haemorrhagic crust, generalized maculopapular rash, facial oedema, tender lymphadenopathy, and. Laboratory findings confirmed a severe hyper-eosinophilia (32%) and lymphopenia (13.5%), while liver function was normal. A diagnosis of DRESS syndrome was finally established. Case management were immediate withdrawal of phenytoin and lamotrigine, followed by multidisciplinary care including intra vena and topical corticosteroids. The patient's condition significantly improved after collaborative comprehensive treatment. Conclusion: Definitive diagnosis decisions requires careful consideration on the correlation of clinical findings, medication history, and hallmark laboratory results, especially in patients with complex comorbidities and intraoral clinical features with characteristics similar to other hypersensitivity reactions. Comprehensive collaborative management, including patient’s and other healthcare professionals collaboration, is crucial for successful treatment.
References
Chen CB, Hung WK, Wang CW, Lee CC, Hung SI, Chung WH. Advances in understanding of the pathogenesis and therapeutic implications of drug reaction with eosinophilia and systemic symptoms: an updated review. Front Med. 2023 June 29;10:1187937.
Husain Z, Reddy BY, Schwartz RA. DRESS syndrome. J Am Acad Dermatol. 2013 May;68(5):693.e1-693.e14.
Ochando Díez-Canseco M, Reguero Capilla M, Domínguez-Romero I, Menéndez-Rivero E, Prados-Castaño M. DRESS syndrome and flare-up due to antiepileptics: how to solve the problem. Neurol Engl Ed. 2025 May;40(4):406–8.
De A, Rajagopalan M, Sarda A, Das S, Biswas P. Drug reaction with eosinophilia and systemic symptoms: An update and review of recent literature. Indian J Dermatol. 2018;63(1):30.
Maverakis E, Ji‐Xu A, Brüggen M. Targeting interleukin‐5 with benralizumab: A novel treatment for drug rash with eosinophilia and systemic symptoms. Allergy. 2022 Aug;77(8):2287–9.
Koomdee N, Pratoomwun J, Jantararoungtong T, Theeramoke V, Tassaneeyakul W, Klaewsongkram J, et al. Association of HLA-A and HLA-B Alleles with Lamotrigine-Induced Cutaneous Adverse Drug Reactions in the Thai Population. Front Pharmacol. 2017 Nov 29;8:879.
Rashid M, Rajan AK, Chhabra M, Kashyap A, Chandran VP, Venkataraman R, et al. Role of human leukocyte antigen in anti-epileptic drugs-induced Stevens–Johnson Syndrome/toxic epidermal necrolysis: A meta-analysis. Seizure Eur J Epilepsy. 2022 Nov;102:36–50.
Anci E, Braun C, Marinosci A, Rodieux F, Midun E, Torres MJ, et al. Viral Infections and Cutaneous Drug-Related Eruptions. Front Pharmacol. 2021 Mar 10;11:586407.
Samim F, Auluck A, Zed C, Williams PM. Erythema Multiforme. Dent Clin North Am. 2013 Oct;57(4):583–96.
Taweesedt PT, Nordstrom CW, Stoeckel J, Dumic I. Pulmonary Manifestations of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome: A Systematic Review. BioMed Res Int. 2019 Sept 24;2019:1–10.
Choudhary S, McLEOD M, Torchia D, Romanelli P. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome. 2013;6(6).
Rama MCR, Bindhu Madhavi G, Mohan A, Prakash RB, Devi BV. Drug rash with eosinophilia and systemic symptoms (DRESS): A report of two cases. J Clin Sci Res. 2023 Oct;12(Suppl 2):S111–4.
Ben Salha W, Moussaoui E, Oualha L, Anoun J, Douki N. Erosive cheilitis as an early manifestation in DRESS syndrome. Clin Case Rep. 2021 Nov;9(11):e05123.
Hambly JL, Haywood A, Hattingh L, Nair RG. Comparison between self‐formulation and compounded‐formulation dexamethasone mouth rinse for oral lichen planus: a pilot, randomized, cross‐over trial. J Investig Clin Dent. 2017 Aug;8(3):e12225.
Ramadas A, Jose R, Arathy S, Kurup S, Chandy M, Kumar S. Systemic absorption of 0.1% triamcinolone acetonide as topical application in management of oral lichen planus. Indian J Dent Res. 2016;27(3):230.
Taléns-Visconti R, Perra M, Ruiz-Saurí A, Nácher A. New Vehiculation Systems of Mometasone Furoate for the Treatment of Inflammatory Skin Diseases. Pharmaceutics. 2022 Nov 22;14(12):2558.
Thongprasom K. A Review of the Effectiveness and Side-Effects of Fluocinolone Acetonide 0.1% in the Treatment of Oral Mucosal Diseases. Acta Stomatol Croat. 2017 Sept 15;51(3):240–7.
Systemic Versus Topical Corticosteroids in the Treatment of DRESS_ A Retrospective Cohort Study Followed by a Meta-Analysis _ American Journal of Clinical Dermatology.
Lopes JP, Lionakis MS. Pathogenesis and virulence of Candida albicans. Virulence. 2022 Dec 31;13(1):89–121.
Faculty of Dental Medicine, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania, Nuncă AM, Coculescu EC, Faculty of Dental Medicine, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania, Coculescu BI, 1.Faculty of Midwifery and Nursing, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania2.Cantacuzino National Military Medical Institute for Research and Development, Bucharest, Romania. THE ROLE OF GENERAL FACTORS IN THE PATHOGENESISOF ORAL CANDIDIASIS. Romanian Arch Microbiol Immunol. 2022 Dec 30;81(4):271–7.
Downloads
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
This work is licensed under a Creative Commons Attribution 4.0 International License.
